Capture of circulating tumor cells from whole blood of prostate cancer patients using geometrically enhanced differential immunocapture (GEDI) and a prostate-specific antibody.
Capture of circulating tumor cells from whole blood of prostate cancer patients using geometrically enhanced differential immunocapture (GEDI) and a prostate-specific antibody.
复制标题
DOI:
10.1039/b917959c
复制
发表时间:
2010-01-07
期刊:
影响因子:
6.1
通讯作者:
Kirby BJ
中科院分区:
文献类型:
--
作者:
Gleghorn JP;Pratt ED;Denning D;Liu H;Bander NH;Tagawa ST;Nanus DM;Giannakakou PA;Kirby BJ
Geometrically-enhanced differential immunocapture (GEDI) and an antibody for prostate-specific membrane antigen (PSMA) are used for high-efficiency and high-purity capture of prostate circulating tumor cells from peripheral whole blood samples of castrate-resistant prostate cancer patients.
登录
查看更多内容
DOI:
10.1073/pnas.0404036101
发表时间:
2004-07-20
影响因子:
11.1
作者:
Krivacic, RT;Ladanyi, A;Bruce, RH
通讯作者:
Bruce, RH
影响因子:
56.9
作者:
Huang, LR;Cox, EC;Sturm, JC
通讯作者:
Sturm, JC
影响因子:
11.5
作者:
Danila, Daniel C.;Heller, Glenn;Scher, Howard I.
通讯作者:
Scher, Howard I.
影响因子:
15
作者:
Adams, Andre A.;Okagbare, Paul I.;Soper, Steven A.
通讯作者:
Soper, Steven A.
DOI:
10.1073/pnas.95.8.4589
发表时间:
1998-04-14
影响因子:
11.1
作者:
Racila, E;Euhus, D;Uhr, JW
通讯作者:
Uhr, JW